4.6 Article

COVID-19 and the UK Biobank-Opportunities and Challenges for Research and Collaboration With Other Large Population Studies

Journal

FRONTIERS IN CARDIOVASCULAR MEDICINE
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fcvm.2020.00156

Keywords

COVID-19; UK Biobank; population studies; precision medicine; epidemiology

Funding

  1. Wellcome Trust Research Training Fellowship [203553/Z/16/Z]
  2. National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Centre at Barts NHS Trust
  3. European Union [825903]
  4. National Institutes of Health [NIH HL134885]
  5. American Heart Association [17POST33400211]
  6. Paul and Ruby Tsai Foundation

Ask authors/readers for more resources

Large population studies such as the UK Biobank provide great opportunities for understanding the pathophysiology, health impact and prognostic factors associated with COVID-19, a condition that has had significant impact on almost everyone around the world. We highlight the vast opportunities, challenges and limitations for research and collaboration from the UK Biobank and other large population studies in helping us better understand and manage both current and potential future pandemics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available